A61K 9/5192
Processes
Official title: {Processes}
A61K9/5192 (Processes) appears on 857 US grants and 1,810 published applications in this corpus.
Search patents in A61K- Granted patents
- 857
- Published applications
- 1,810
- Assignees
- 916
- Inventors
- 4,000
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 5 | 0 |
| 1999 | 10 | 0 |
| 2000 | 8 | 0 |
| 2001 | 7 | 5 |
| 2002 | 5 | 11 |
| 2003 | 8 | 34 |
| 2004 | 9 | 32 |
| 2005 | 3 | 28 |
| 2006 | 8 | 46 |
| 2007 | 6 | 39 |
| 2008 | 4 | 46 |
| 2009 | 11 | 56 |
| 2010 | 14 | 62 |
| 2011 | 23 | 45 |
| 2012 | 26 | 51 |
| 2013 | 37 | 56 |
| 2014 | 40 | 65 |
| 2015 | 39 | 66 |
| 2016 | 46 | 84 |
| 2017 | 40 | 85 |
| 2018 | 36 | 70 |
| 2019 | 67 | 88 |
| 2020 | 73 | 108 |
| 2021 | 55 | 114 |
| 2022 | 62 | 123 |
| 2023 | 49 | 114 |
| 2024 | 54 | 118 |
| 2025 | 60 | 126 |
| 2026 | 39 | 138 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Long-acting low-toxicity novel cationic lipid compounds and composition thereof29 Sep 2026US 12,746,208 B2Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.
- Particle composition comprising sialic acid binding ligand29 Sep 2026US 12,746,211 B2Cytodigm, Inc.
- Methods of producing extracellular vesicles8 Sep 2026US 12,728,098 B2Lonza Sales AG
- Formulation to deliver lipophilic active ingredients8 Sep 2026US 12,728,099 B2Performs S.R.L.
- Method of preparing hyaluronic acid nanoparticles8 Sep 2026US 12,728,100 B2Amorepacific Corporation
- Modular multiplatform system for mrna drug production8 Oct 2026US 2026/0306407 A1BioNTech SE
- Oral targeted nano delivery systems containing geniposide and preparation methods thereof8 Oct 2026US 2026/0306417 A1Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
- Silica-based nanoparticles for sustained release of hydrophobic drug, preparation method therefor, and transdermal drug delivery system comprising same8 Oct 2026US 2026/0306418 A1Mpios Inc.
- Stable polymer-lipid nanoparticle for drug binding and delivery, especially with anticancer properties, and a method for producing stable polymer-lipid nanoparticles carrying drugs, especially with anticancer properties8 Oct 2026US 2026/0306420 A1Bs Biotechna Spolka Akcyjna
- Method for synthesizing zeolite nanoparticles in a saline phosphate buffer and associated nanoparticles, suspensions, pharmaceutical composition and uses8 Oct 2026US 2026/0306532 A1Centre National De La Recherche Scientifique
Most cited
By later US patents
- Cyclodextrin polymers for carrying and releasing drugs324US 6,048,736 A2000
- Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof257US 5,916,596 AVivorx Pharmaceuticals, Inc. · 1999
- Injectable compositions, nanoparticles useful therein, and process of manufacturing same232US 4,107,288 APharmaceutical Society of Victoria · 1978
- Rapidly disintegrating solid oral dosage form217US 6,316,029 B1Flak Pharma International, Ltd. · 2001
- Methods and compositions useful for administration of chemotherapeutic agents204US 6,096,331 AVivorx Pharmaceuticals, Inc. · 2000